Coriolus versicolor (PSK/PSP) for Immune Function
Verdict: Published
Across 4 PubMed studies, the evidence for Coriolus versicolor (PSK/PSP) in Immune Function grades Tier C — weak evidence.
C 🟠 C Weak Evidence Published
Why this grade7-layer evidence engine
⚖️
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditableRaw score 0.57
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published
Confidence
47%
Conflicting evidence
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)
▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.568
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (3 篇 > 0 negative)
- tier_strict_requirement_check — | B→C 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
PubMed studies (4)L2 · primary research & systematic reviews
Phase 1 Clinical Trial of Trametes versicolor in Women with Breast Cancer
Finding: Dose-related increases in lymphocyte counts (6-9 g/day), NK functional activity (6 g/day), CD8+ T cells and CD19+ B cells after post-radiotherapy supplementation; no p-values reported (phase I).
View on PubMed Trametes versicolor (Synn. Coriolus versicolor) Polysaccharides in Cancer Therapy: Targets and Efficacy
Finding: Consistent upregulation of IL-2/IL-12/IFN-γ and NK/lymphocyte counts across trials; meta-analytic 9% absolute reduction in 5-year mortality in adjuvant cancer setting.
View on PubMed Immunomodulatory Properties of Coriolus versicolor: The Role of Polysaccharopeptide
Finding: PSP increased NK cytotoxic function and lymphocyte counts in breast cancer patients; healthy donors showed increased IFN-γ and Th cell counts (qualitative synthesis).
View on PubMed Can polysaccharide K improve therapeutic efficacy and safety in gastrointestinal cancer? a systematic review and network meta-analysis
Finding: PSK + chemo improved 3y OS (OR 1.54, 95% CI 1.18-2.13) and 5y OS (OR 2.94, 95% CI 1.00-8.33); reduced leukopenia (OR 0.60) — indirect immune-preservation signal.
View on PubMed Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …
L4a US FDA
Cautious
Turkey tail are known to have anti-cancer, antiviral, antibacterial and antifungal effects as well as immune modulating effects. ... The claims on your website establish that your products are drugs under section 201(g)(1)(B) of the FD&C Act because they were intended for use in the cure, mitigation, treatment, or prevention of disease. source↗
L4b EU EFSA
Against
Commission Implementing Decision of 6 December 2021 (C(2021) 8744 final) terminating the procedure for authorising the placing on the market within the Union of the novel food 'Coriolus versicolor' without updating the Union list of novel foods pursuant to Regulation (EU) 2015/2283. source↗